South Africa’s Afrigen makes mRNA COVID vaccine.
“We will only make our clinical trial batch probably in six months from now, (meaning) … fit for humans. And the target is November 2022,”
“We will only make our clinical trial batch probably in six months from now, (meaning) … fit for humans. And the target is November 2022,”